Barrington Research Lowers Earnings Estimates for Cinemark

Cinemark Holdings Inc (NYSE:CNKFree Report) – Stock analysts at Barrington Research reduced their Q3 2025 EPS estimates for shares of Cinemark in a research note issued on Thursday, October 16th. Barrington Research analyst P. Sholl now expects that the company will earn $0.40 per share for the quarter, down from their previous forecast of $0.42. Barrington Research has a “Outperform” rating and a $36.00 price target on the stock. The consensus estimate for Cinemark’s current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark’s Q4 2025 earnings at $0.64 EPS, FY2025 earnings at $1.41 EPS, Q2 2026 earnings at $0.88 EPS, Q4 2026 earnings at $0.68 EPS, FY2026 earnings at $2.04 EPS and FY2027 earnings at $2.49 EPS.

Cinemark (NYSE:CNKGet Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.78 by ($0.15). The company had revenue of $940.50 million for the quarter, compared to analyst estimates of $942.14 million. Cinemark had a return on equity of 59.16% and a net margin of 9.13%.The firm’s quarterly revenue was up 28.1% on a year-over-year basis. During the same quarter last year, the company earned $0.32 EPS.

Other research analysts also recently issued research reports about the stock. Zacks Research upgraded shares of Cinemark from a “strong sell” rating to a “hold” rating in a research report on Friday, October 3rd. Wall Street Zen upgraded shares of Cinemark from a “sell” rating to a “hold” rating in a research report on Sunday, August 10th. Weiss Ratings restated a “hold (c+)” rating on shares of Cinemark in a research report on Wednesday, October 8th. Wells Fargo & Company restated an “overweight” rating and set a $33.00 target price (down from $36.00) on shares of Cinemark in a research report on Monday, August 4th. Finally, Roth Capital cut their target price on shares of Cinemark from $36.00 to $34.00 and set a “buy” rating on the stock in a research report on Monday, August 4th. Nine research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $35.40.

Get Our Latest Analysis on Cinemark

Cinemark Stock Down 0.2%

Shares of NYSE CNK opened at $26.45 on Friday. The firm’s 50-day simple moving average is $26.82 and its 200 day simple moving average is $28.74. The company has a market cap of $3.04 billion, a price-to-earnings ratio of 14.45, a price-to-earnings-growth ratio of 1.88 and a beta of 1.75. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 4.32. Cinemark has a 12-month low of $23.12 and a 12-month high of $36.28.

Cinemark Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 10th. Shareholders of record on Wednesday, August 27th were given a dividend of $0.08 per share. The ex-dividend date was Wednesday, August 27th. This represents a $0.32 dividend on an annualized basis and a yield of 1.2%. Cinemark’s dividend payout ratio is presently 17.49%.

Insider Activity at Cinemark

In other news, EVP Melissa Thomas sold 7,200 shares of the company’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $25.17, for a total value of $181,224.00. Following the completion of the sale, the executive vice president directly owned 203,768 shares of the company’s stock, valued at $5,128,840.56. This represents a 3.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.10% of the stock is currently owned by company insiders.

Institutional Trading of Cinemark

Institutional investors and hedge funds have recently modified their holdings of the stock. EverSource Wealth Advisors LLC increased its stake in shares of Cinemark by 118.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock valued at $28,000 after acquiring an additional 507 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new stake in shares of Cinemark in the 2nd quarter valued at about $47,000. GAMMA Investing LLC increased its stake in shares of Cinemark by 66.2% in the 2nd quarter. GAMMA Investing LLC now owns 3,474 shares of the company’s stock valued at $105,000 after acquiring an additional 1,384 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Cinemark by 242.9% in the 1st quarter. Russell Investments Group Ltd. now owns 3,532 shares of the company’s stock valued at $88,000 after acquiring an additional 2,502 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new stake in shares of Cinemark in the 2nd quarter valued at about $170,000.

About Cinemark

(Get Free Report)

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.

Read More

Earnings History and Estimates for Cinemark (NYSE:CNK)

Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.